Skip to main content

Table 1 Schedule of tests and follow-up visits

From: Measuring aniseikonia and investigating neuroplasticity and image factors in amblyopia (MAGNIFY): study protocol for a randomised clinical trial

Measures Registration Baseline assessment 5 weeks 10 weeks 15 weeks
Demographics     
Visual acuity a
Ocular alignment
Motor fusion b
Stereopsis b
Subjective aniseikonia tests     
Biometry     
OCT     
PedEyeQ     
Serious adverse events   
Spectacle adherence   
Allocation     
  1. aUnaided visual acuity is measured at the registration visit if not available from the referrer. The Keeler LogMAR chart will be used in the study for those who require measurement at the registration visit
  2. bTests done by study clinicians only if relevant information is not available from the referrer